Dr. John A. Chabot, MD

Dr. Chabot practices at Columbia University Irving Medical Center in New York, New York.

Dr. Chabot's NPI, 1447334966, was assigned on October 24, 2006. Dr. Chabot graduated from Geisel School Of Medicine At Dartmouth in 1984. Dr. Chabot holds New York license 166730-1.

Dr. Chabot's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Chabot's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Chabot is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Chabot to 1 more hospital, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chabot practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Chabot's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Chabot is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Chabot's licenses on file in 4 states: New York, Florida, Connecticut and New Jersey.

Dmand AI lists colon removal, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Chabot treats.

CMS data shows 542 Medicare services from Dr. Chabot across 11 procedure codes in 2024, for 366 Medicare patients. Medicare paid $98,341 for them.

CMS counts 366 Medicare patients who saw Dr. Chabot in 2024. The largest group is 75 to 84, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chabot's median patient age at 70, with 53% women.

In 2024, Dr. Chabot wrote 29 Medicare Part D claims for 23 patients. 83% of them were for generic drugs. They cover 2 drugs, with $83 in total drug cost. In 2022, CMS named 53 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Chabot for performance year 2024, reported through an alternative payment model (APM). Dr. Chabot accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chabot as offering telehealth.

Dmand AI links 144 papers to Dr. Chabot, published from 2006 to 2024. 2019 was the busiest year, with 9. The most frequent topics are Pancreatic Neoplasms, Pancreatectomy and Adenocarcinoma. Dr. Chabot has published most often in J Gastrointest Surg. Dr. Chabot's most frequent co-authors are Beth Anne Schrope, MD, Michael D. Kluger, MD, MPH and John Dennis Allendorf, MD.

CMS Open Payments shows 18 general payments to Dr. Chabot from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. Celgene Corporation paid the most, $1,622.

Dmand AI lists 18 awards for Dr. Chabot, most recently CMS Stage 1 2012 in 2012.

Dr. Chabot graduated from Geisel School Of Medicine At Dartmouth in 1984. Dr. Chabot is a member of ACS.

Dr. Chabot is in network with 14 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.